Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Affimed NV (AFMD)
  7. News

AFMD

Affimed NV News

FREE AFMD REPORT

Company Name Stock Ticker Symbol Market Type
Affimed NV AFMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.03 2.52% 1.22 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.19 1.17 1.235 1.20 1.19
more quote information »

Recent News

Date Time Source Heading
1/26/20237:21IHNWFeaturedUCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023
1/09/202306:30GLOBEAffimed Reports on Corporate Progress and Provides..
12/22/202206:30GLOBEAffimed Announces Approval of Clinical Trial Application in..
12/12/202214:46TRMNAffimed Plunges after Detailing New Plans
12/12/202211:26TRMNWells Fargo Reaffirms Their Buy Rating on Affimed (AFMD)
12/12/202210:00GLOBEAffimed Presents Updated Data for AFM28 Demonstrating..
12/12/202208:16EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/12/202206:05TRMNAffimed (AFMD) Receives a Buy from Berenberg Bank
12/10/202215:00GLOBEAffimed Reports Topline Data from AFM13 Monotherapy Phase 2..
12/10/202214:20GLOBEAffimed Provides Updated Clinical Data from Phase 1/2 Study..
12/01/202216:05GLOBEAffimed to Host Investor Event Highlighting AFM13 Clinical..
11/17/202223:35TRMNSVB Securities Sticks to Its Buy Rating for Affimed (AFMD)
11/15/202206:47EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/15/202206:30GLOBEAffimed Reports Third Quarter 2022 Financial Results..
11/14/202206:05TRMNAffimed (AFMD) Receives a Buy from Berenberg Bank
11/07/202215:55TRMNAffimed (AFMD) Gets a Buy from SVB Securities
11/07/202208:05GLOBEAffimed Provides Data Update from Two Phase 1/2a Trials with..
11/04/202206:30GLOBEAffimed to Report Third Quarter 2022 Financial Results &..
11/04/202206:05TRMNBerenberg Bank Keeps Their Buy Rating on Affimed (AFMD)
11/03/202209:24EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/03/202209:15GLOBEAffimed and Artiva Biotherapeutics Announce Partnership to..
11/03/202209:05GLOBEAffimed Announces Presentation of Phase 1/2 Data from AFM13..
11/01/202206:30GLOBEAffimed to Present at the 2022 Jefferies London Healthcare..
10/05/202208:05GLOBEAffimed Announces Two Clinical Update Presentations on its..
9/01/202206:30GLOBEAffimed to Present at Upcoming Investor Conferences
8/16/202204:47TRMNSVB Securities Sticks to Their Buy Rating for Affimed (AFMD)
8/12/202206:05TRMNAffimed (AFMD) Gets a Buy from Berenberg Bank
8/11/202206:30GLOBEAffimed Reports Second Quarter 2022 Financial Results and..
8/04/202206:30GLOBEAffimed to Report Second Quarter 2022 Financial Results &..
6/30/202216:00GLOBEAffimed Establishes Scientific Advisory Board
6/23/202216:30TRMNSVB Securities Thinks Affimed’s Stock is Going to Recover
6/23/202207:29EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/10/202210:31GLOBEAffimed Presents Preclinical Data of Novel Innate Cell..
6/01/202206:54EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/01/202206:30GLOBEAffimed Reports First Quarter 2022 Financial Results and..
5/26/202217:05GLOBEAffimed Highlights Trial Designs of Three AFM24 Ongoing..
5/26/202206:30GLOBEAffimed to Present at the 2022 Jefferies Healthcare..
5/24/202206:30GLOBEAffimed Announces Annual General Meeting of Shareholders
5/16/202208:00GLOBEAffimed Presents Data on Innate Cell Engagers AFM24 and..
5/12/202210:31GLOBEAffimed to Present Preclinical Data Demonstrating Cytotoxic..
5/09/202215:25EDGARStatement of Ownership (sc 13g)
5/06/202216:02GLOBEAffimed Provides Update on ASCO AFM13-104 Oral Presentation
5/01/202212:42TRMNLeerink Partners Thinks Affimed’s Stock is Going to Recover
4/27/202217:20GLOBECORRECTING and REPLACING -- Affimed N.V.
4/27/202216:05GLOBEAffimed Announces Clinical Update and Trial in Progress..
4/21/202206:10EDGARStatement of Ownership (sc 13g)
4/18/202216:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/18/202211:28GLOBEAffimed Announces Closing of Public Offering of Common..
4/14/202216:18EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/12/202222:02GLOBEAffimed Announces Pricing of Upsized $90 Million Public..
4/12/202216:02GLOBEAffimed Announces Proposed Public Offering of Common Shares